Patient characteristics, demographic variables, and clinical and radiological data
| Data available (n) | Progressive vascular brain damage (n = 23) | No progressive vascular brain damage (n = 78) | |
|---|---|---|---|
| *p<0.05; †therapy: speech, physio, ergonomic; ‡CNS: Canadian Neurological Scale (range 0–10); §AT, atherothrombosis; CE, cardial embolism; LAC, lacunar. | |||
| Age (mean, SD) | 101 | 70.2 (10.1) | 60.6 (10.8)* |
| Level of education, % low | 101 | 39.1% | 43.6% |
| Gender, % female | 101 | 65.2% | 39.7%* |
| Infarct/haemorrhage | 101 | 21/2 | 70/8 |
| Left/right | 96 | 7/15 | 30/44 |
| Lacunar/territorial | 90 | 17/4 | 46/23 |
| Asymptomatic, present/absent | 101 | 7/16 | 20/58 |
| Leukoaraiosis, present/absent | 101 | 4/19 | 9/69 |
| Atrophy, present/absent | 101 | 16/7 | 39/39 |
| Hypertension, present/absent | 101 | 12/11 | 29/49 |
| Diabetes, present/absent | 100 | 4/19 | 9/68 |
| Heart failure, present/absent | 99 | 4/19 | 8/68 |
| Cholesterol, present/absent | 71 | 1/14 | 11/45 |
| COPD, present/absent | 100 | 0/23 | 5/72 |
| Carotid stenosis, present/absent | 99 | 3/22 | 7/77 |
| AT/CE/LAC§ | 91 | 21/2/46 | 3/1/18 |
| Current smoking, present/absent | 101 | 5/18 | 31/47 |
| Therapy†, present/absent | 101 | 14/9 | 40/38 |
| Stroke severity by CNS‡, mean (SD) | 101 | 8.2 (1.6) | 8.8 (1.3) |
| MMSE score, mean (SD) | 101 | 25.8 (2.8) | 26.6 (3.1) |